Advanced search
Publication Cover
Seminars in Ophthalmology Volume 26, 2011 - Issue 1
Submit an article Journal homepage
116
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Vitreous Web after Pars Plana Vitrectomy and Bevacizumab with Fluid-Air Exchange

Allen ChiangDepartment of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, CA, USA
,
Shantan ReddyDepartment of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, CA, USA
,
Irena TsuiDepartment of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, CA, USA
&
Jean-Pierre HubschmanDepartment of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, CA, USACorrespondence[email protected]
Pages 25-27 | Received 17 May 2010, Accepted 14 Nov 2010, Published online: 28 Jan 2011

REFERENCES

  • Spaide RF, Laud K, Fine HF. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina. 2006; 26:383–390.
  • Avery RL, Pieramici DJ, Rabena MD. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006; 113:363–72.
  • Spaide RF, Laud K, Fine HF. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina. 2006; 26:383–90.
  • Rich RM, Rosenfeld PJ, Puliafito CA. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina. 2006; 26:495–511.
  • Chen CY, Wong TY, Heriot WJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study. Am J Ophthalmol. 2007; 143:510–2.
  • Jonas JB, Spandau UH, Rensch F. Infectious and noninfectious endophthalmitis after intravitreal bevacizumab. J Ocular Pharmacol Ther. 2007; 23:240–242.
  • Rosenfeld PJ, Brown DM, Heier JS. MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006; 355:1419–1431.
  • Mamalis N, Edelhauser HF, Dawson DG. Toxic anterior segment syndrome. J Cataract Refract Surg. 2006; 32:324–33.
  • Remick DG, Kunkel RG, Larrick JW. Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest. 1987; 56:583–90.
  • Schepens CL. Clinical and research aspects of subtotal open-sky vitrectomy. XXXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 1981; 91:143–171.
  • Sebestyen JG. Fibrinoid syndrome: a severe complication of vitrectomy surgery in diabetics. Ann Ophthalmol. 1982; 14(9):853–6.
  • Castellarin Grigorian, R, Bhagat N. Vitrectomy with silicone oil infusion in severe diabetic retinopathy. Br J Ophthalmol. 2003; 87(3):318–321.
  • Wickremasinghe SS, Michalova K, Gilhotra J. Acute intraocular inflammation after intravitreous injection of bevacizumab for treatment of neovascular age-related macular degeneration. Ophthalmology. 2008; 115:1911–1915.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.